stonena7/iStock via Getty Images
- The European Medicines Agency’s Committee for Veterinary Medicinal Products has issued a positive opinion for the marketing authorization of Zoetis’ (NYSE:ZTS) Lenivia (izenivetmab) to ease osteoarthritis pain in dogs.
- A decision is expected by the end of the year with
